Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Foreign Aneusumab, Atc N02Cd03 For The Period 01.07.2025 - 30.06.2027

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 109240395

  Document Type - Tender Notices

Description - Description: Section 130a paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to include framework discount contracts for the drugs to be issued at the expense of the statutory health insurance companies. With regard to the relevant legal regulations on the awarding of public orders, a regular process of active ingredient, formal award procedures takes place according to the regulations of the 4th part of the GWB through DAK health. For medicines to be named by the bidder in Appendix 2 to the contract to the above. The active ingredient Foreign Ananzumab, ATC N02CD03, intends to conclude the DAK health until the entry into force of new pharmaceutical discount co

Gt Ref Id - 109240395

Deadline - May 05, 2027